This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zaas, A. K.
Right arrow Articles by Perfect, J. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zaas, A. K.
Right arrow Articles by Perfect, J. R.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, November 2003, p. 5233-5235, Vol. 41, No. 11
0095-1137/03/$08.00+0     DOI: 10.1128/JCM.41.11.5233-5235.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.

Risk of Fungemia Due to Rhodotorula and Antifungal Susceptibility Testing of Rhodotorula Isolates

Aimee K. Zaas,1,2* Molly Boyce,1 Wiley Schell,1 Barbara Alexander Lodge,1,2 Jackie L. Miller,1 and John R. Perfect1,2

Duke University Mycology Research Unit,1 Division of Infectious Diseases and International Health, Department of Internal Medicine, Duke University Medical Center, Durham, North Carolina 277052

Received 22 April 2003/ Returned for modification 26 June 2003/ Accepted 4 August 2003

Rhodotorula infections occur among patients with immunosuppression and/or central venous catheters. Using standardized methods (NCCLS M27-A), we determined the antifungal susceptibilities of 10 Rhodotorula bloodstream infection isolates. Patient information was collected for clinical correlation. The MICs of amphotericin B and posaconazole were the lowest, and the MICs of triazoles and echinocandins were higher than those of other antifungal agents.

* Corresponding author. Mailing address: Box 3824, Duke University Medical Center, Durham, NC 27705. Phone: (919) 684-2660. Fax: (919) 684-8902. E-mail: drs_zaas{at}yahoo.com.

Journal of Clinical Microbiology, November 2003, p. 5233-5235, Vol. 41, No. 11
0095-1137/03/$08.00+0     DOI: 10.1128/JCM.41.11.5233-5235.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Pfaller, M. A., Diekema, D. J., Gibbs, D. L., Newell, V. A., Bijie, H., Dzierzanowska, D., Klimko, N. N., Letscher-Bru, V., Lisalova, M., Muehlethaler, K., Rennison, C., Zaidi, M., the Global Antifungal Surveillance Group, (2009). Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: 10.5-Year Analysis of Susceptibilities of Noncandidal Yeast Species to Fluconazole and Voriconazole Determined by CLSI Standardized Disk Diffusion Testing. J. Clin. Microbiol. 47: 117-123 [Abstract] [Full Text]  
  • Savini, V., Sozio, F., Catavitello, C., Talia, M., Manna, A., Febbo, F., Balbinot, A., Di Bonaventura, G., Piccolomini, R., Parruti, G., D'Antonio, D. (2008). Femoral Prosthesis Infection by Rhodotorula mucilaginosa. J. Clin. Microbiol. 46: 3544-3545 [Abstract] [Full Text]  
  • Leaw, S. N., Chang, H. C., Sun, H. F., Barton, R., Bouchara, J.-P., Chang, T. C. (2006). Identification of medically important yeast species by sequence analysis of the internal transcribed spacer regions.. J. Clin. Microbiol. 44: 693-699 [Abstract] [Full Text]  
  • Serena, C., Marine, M., Pastor, F. J., Nolard, N., Guarro, J. (2005). In vitro interaction of micafungin with conventional and new antifungals against clinical isolates of Trichosporon, Sporobolomyces and Rhodotorula. J Antimicrob Chemother 55: 1020-1023 [Abstract] [Full Text]  
  • Gomez-Lopez, A., Mellado, E., Rodriguez-Tudela, J. L., Cuenca-Estrella, M. (2005). Susceptibility profile of 29 clinical isolates of Rhodotorula spp. and literature review. J Antimicrob Chemother 55: 312-316 [Abstract] [Full Text]  
  • Diekema, D. J., Petroelje, B., Messer, S. A., Hollis, R. J., Pfaller, M. A (2005). Activities of Available and Investigational Antifungal Agents against Rhodotorula Species. J. Clin. Microbiol. 43: 476-478 [Abstract] [Full Text]  
  • Pfaller, M. A., Diekema, D. J. (2004). Rare and Emerging Opportunistic Fungal Pathogens: Concern for Resistance beyond Candida albicans and Aspergillus fumigatus. J. Clin. Microbiol. 42: 4419-4431 [Full Text]  
  • Serena, C., Pastor, F. J., Ortoneda, M., Capilla, J., Nolard, N., Guarro, J. (2004). In Vitro Antifungal Susceptibilities of Uncommon Basidiomycetous Yeasts. Antimicrob. Agents Chemother. 48: 2724-2726 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»